Point72 Hong Kong LTD Cue Biopharma, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.49 - $5.92 $5,428 - $12,905	-2,180 Reduced 90.31%	234 $1,000
Q1 2022 May 16, 2022	BUY	$4.41 - $12.28 $10,645 - $29,643	2,414 New	2,414 $12,000
Q1 2021 May 17, 2021	SELL	$11.2 - $16.09 $459 - $659	-41 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$11.12 - $16.4 $455 - $672	41 New	41 $1,000
Q3 2020 Nov 16, 2020	SELL	$15.05 - $23.54 $195 - $306	-13 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.7 - $30.73 $165 - $399	13 New	13 $0

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.